Evidence map›Paper›PMID 35384004›Full record

SynthesisBritish journal of clinical pharmacology2022

How do they add up? The interaction between the placebo and treatment effect: A systematic review.

Rémy Boussageon, Jeremy Howick, Raphael Baron, Florian Naudet, Bruno Falissard, Ghina Harika-Germaneau, Issa Wassouf, François Gueyffier, Nemat Jaafari, Clara Blanchard

Open access · hybridAbstract readSystematic Review
In one paragraph

Synthesis in British journal of clinical pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Article
  8. Placebo and nocebo effect in pain.Handbook of clinical neurology · 2025
    Review
  9. Article
  10. Article
  11. Article
  12. Harnessing placebo: Lessons from psychedelic science.Journal of psychopharmacology (Oxford, England) · 2023
    Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 2 countries.

Rémy BoussageonLaboratoire de Biométrie et Biologie Evolutive, Equipe Evaluation et modélisation des effets thérapeutiques, Lyon, France.
Jeremy HowickFaculty of Philosophy, University of Oxford, Radcliffe Infirmary Quarter, Oxford, UK.ORCID 0000-0003-0280-7206
Raphael BaronCollège Universitaire de Médecine Générale, University of Lyon, Lyon, France.
Florian NaudetUniversity of Rennes 1, Rennes, France.ORCID 0000-0003-3760-3801
Bruno FalissardCESP/INSERM U1018 (Centre de Recherche en Epidemiologie et Santé des Populations), Paris, France.ORCID 0000-0002-2418-4954
Ghina Harika-GermaneauUnité de recherche clinique intersectorielle en psychiatrie à vocation régionale Pierre Deniker du Centre Hospitalier Henri Laborit, France.
Issa WassoufUnité de recherche clinique intersectorielle en psychiatrie à vocation régionale Pierre Deniker du Centre Hospitalier Henri Laborit, France.
François GueyffierLaboratoire de Biométrie et Biologie Evolutive, Equipe Evaluation et modélisation des effets thérapeutiques, Lyon, France.ORCID 0000-0002-9921-0977
Nemat JaafariUnité de recherche clinique intersectorielle en psychiatrie à vocation régionale Pierre Deniker du Centre Hospitalier Henri Laborit, France.ORCID 0000-0003-2669-4509
Clara BlanchardDepartment of General Practice, University of Poitiers, Poitiers, France.ORCID 0000-0001-9007-6954
Centre Hospitalier Henri Laborit · FRLaboratoire de Biométrie et Biologie Evolutive · FRCentre Hospitalier Universitaire de Rennes · FRInserm · FRUniversité Claude Bernard Lyon 1 · FRUniversité de Poitiers · FRUniversity of Oxford · GB

Funding

Medical Research Council MR/V020706/1
6 · The paper itself

Abstract

aimThe placebo effect and the specific effect are often thought to add up (additive model). Whether additivity holds can dramatically influence the external validity of a trial. This assumption of additivity was tested by Kleijnen et al in 1994 but the data produced since then have not been synthetized. In this review, we aimed to systematically review the literature to determine whether additivity held.

methodsWe searched Medline and PsychInfo up to 10 January 2019. Studies using the balanced placebo design (BPD), testing two different strengths of placebos, were included. The presence of interaction was evaluated by comparing each group in the BPD with analysis of variance or covariance.

resultsThirty studies were included and the overall risk of bias was high: four found evidence of additivity and 16 studies found evidence of interaction (seven had evidence of positive additivity).

conclusionEvidence of additivity between placebo and specific features of treatments was rare in included studies. We suggest interventions for placebo-sensitive ailments should be tested in trials designed to take interactions seriously once an exploratory RCTs has proven their efficacy with sufficient internal validity.

Indexed as

Placebo EffectHumansclinical trialsdrug effectevidence-based practiceplacebotherapeutic alliancetreatment outcome

Identifiers

PMID35384004
PMCPMC9545282
OpenAlexW4225318411

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.